SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D)
OF THE SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported) June 7, 2002.
ISTA PHARMACEUTICALS, INC.
| Delaware | 00-31255 | 33-0511729 | ||
| (State or other jurisdiction of incorporation) | (Commission File Number) | (IRS Employer Identification No.) |
15279 Alton Parkway, Suite 100, Irvine, California 92618
Registrant’s telephone number, including area code (949) 788-6000
N/A
| ITEM 5. OTHER EVENTS | ||||||||
| Item 7. FINANCIAL STATEMENTS AND EXHIBITS | ||||||||
| SIGNATURE | ||||||||
| INDEX TO EXHIBITS | ||||||||
| EXHIBIT 99.1 | ||||||||
| EXHIBIT 99.2 | ||||||||
ITEM 5. OTHER EVENTS
On June 7, 2002, ISTA Pharmaceuticals, Inc. (“ISTA”) and R.P. Scherer West, Inc. doing business as SP Pharmaceuticals (“SP”), a subsidiary of Cardinal Health, Inc., entered into a Master Services Agreement for the manufacture and production of commercial quantities of Vitrase®, ISTA’s proprietary compound for the treatment of vitreous hemorrhage.
A further description of the agreement is set forth in the press release disseminated by ISTA on July 9, 2002. The press release is attached to this Report as Exhibit 99.2 and is incorporated herein by reference.
ITEM 7. FINANCIAL STATEMENTS AND EXHIBITS
| (c) | EXHIBITS | |||
| The following exhibits are filed as part of this report, where indicated. | ||||
| 99.1 | Master Services Agreement by and between ISTA Pharmaceuticals, Inc. and R.P. Scherer West, Inc. doing business as SP Pharmaceuticals, dated as of June 7, 2002. | |||
| 99.2 | Press Release issued July 9, 2002 by ISTA Pharmaceuticals, Inc. | |||
-1-
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| ISTA PHARMACEUTICALS, INC. | |
/s/ Vicente Anido, Jr., Ph.D. Vicente Anido, Jr., Ph.D. President and Chief Executive Officer | |
| Date: July 9, 2002 |
-2-
ISTA PHARMACEUTICALS, INC.
Current Report on Form 8-K
INDEX TO EXHIBITS
| Exhibit No. | Description | |
| 99.1 | Master Services Agreement by and between ISTA Pharmaceuticals, Inc. and R.P. Scherer West, Inc. doing business as SP Pharmaceuticals, dated as of June 7, 2002. | |
| 99.2 | Press Release issued July 9, 2002 by ISTA Pharmaceuticals, Inc. |
-3-
